Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy
David A. Morrow, MDa,
Elliott M. Antman, MD, FACCa,
Milenko Tanasijevic, MDb,
Nader Rifai, PhDc,
James A. de Lemos, MDa,
Carolyn H. McCabe, BSa,
Christopher P. Cannon, MD, FACCa and
Eugene Braunwald, MD, FACCa
a Department of Medicine, Brigham and Womens Hospital, Boston, Massachusetts, USA
b Department of Pathology, Brigham and Womens Hospital, Boston, Massachusetts, USA
c Department of Laboratory Medicine, Childrens Hospital, Boston, Massachusetts, USA

View larger version (21K):
[in a new window]
|
Figure 1 Clinical outcomes at 14 days stratified by baseline cTnI results (n = 341). D/MI/UR = death, MI or urgent revascularization.
|
|

View larger version (26K):
[in a new window]
|
Figure 2 Clinical outcomes at 14 days for patients treated with enoxaparin versus UFH stratified by 0- to 24-h cTnI results. CI = confidence interval; D/MI/UR = death, MI or urgent revascularization; RR = relative risk of the outcome for patients treated with enoxaparin versus UFH.
|
|
|